LGND - Ligand Pharmaceuticals Incorporated Stock Trading

Ligand Pharmaceuticals Incorporated(NASDAQ: LGND) stock trading, description, contact, officers and directors.

About Ligand Pharmaceuticals Incorporated

Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand s proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.

Stock Information

Ligand Pharmaceuticals Incorporated Company Name:

LGND Stock Symbol:

NASDAQ Market:

LGND LGND Quote LGND Short LGND News LGND Articles LGND Message Board

Get LGND Alerts

News, Short Squeeze, Breakout and More Instantly...

LGND - Ligand Reports First Quarter 2022 Financial Results

Conference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2022 and provided an operating forecast and program updates. Ligand management will host a conf...
LGND - Sermonix Announces Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

COLUMBUS, Ohio, April 28, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated metastatic breast and gynecological cancers, today announced two abstracts accepted for presenta...
LGND - Ligand to Report First Quarter Financial Results on May 4

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will report first quarter 2022 financial results after the close of the U.S. financial markets on Wednesday, May 4, 2022 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Speakers on the call will in...